Perimenopause Care in Philadelphia, PA: What Actually Helps

By the time most Philadelphia women come into clinic asking about perimenopause, they have already gone through three or four versions of being dismissed. The cycles are weird, but "you're too young." The sleep is broken, but "try magnesium." The brain fog is real, but "maybe an antidepressant." The joints ache, but "try yoga." Meanwhile, the hormonal picture that explains most of the symptoms together is sitting right there, untested and unaddressed. Perimenopause is the hormonal transition that precedes menopause. For most women it begins in the late 30s to mid 40s and lasts 4 to 10 years. The cause is not a steady decline in estrogen - it is wild variability. Estrogen swings up and down within and across cycles. Progesterone drops first, often years before estrogen does. The symptoms reflect that variability and overlap heavily with what a busy primary care visit will attribute to stress, sleep, or thyroid. This page is how we actually approach perimenopause at Fishtown Medicine in Philadelphia: the workup, the symptom-by-symptom breakdown, and what the evidence says about hormone therapy in 2026.

What perimenopause actually looks like

The presentations vary enormously, but here are the patterns we see most:

• Cycles that are still occurring but have become unpredictable. Shorter cycles, heavier flow, sometimes skipped months, sometimes spotting. The cycle change is often the first sign.
• Sleep disruption that does not respond to the usual sleep hygiene. Waking at 3 AM, hot at night, anxious wake-ups.
• Hot flashes and night sweats. Often dismissed as "you're too young." Not too young.
• Brain fog and memory complaints. Word-finding difficulty, calendar slips, a sense of mental sharpness fading.
• Mood changes. Anxiety and irritability often more than depression in the early years. Treated as a psychiatric problem at most practices.
• Joint pain. The estrogen-arthritic-symptoms link is real and underappreciated. Often the second or third complaint and rarely connected back to perimenopause.
• Weight redistribution. Central weight gain that did not used to happen, even with the same diet and training.
• Vaginal dryness, libido changes, urinary frequency or urgency. The "genitourinary syndrome of menopause" starts in perimenopause.

The symptoms overlap with thyroid disease, depression, fibromyalgia, sleep apnea, and a half-dozen other things. A real workup distinguishes between them.

What a real perimenopause workup includes

A 90-minute visit at Fishtown Medicine builds the full picture. The history is most of the work: cycle pattern over the last year or two, symptom inventory, family history of early menopause, surgical history, medication history, sleep, training, alcohol, current contraception. Then the labs. The labs we usually run for someone presenting with perimenopausal symptoms:

• FSH and estradiol. Tricky to interpret in perimenopause because of the variability, but worth having a baseline. FSH is more useful as a confirmatory finding than as a screening tool.
• TSH and free T4. Thyroid disease mimics so much of this.
• CBC. Iron-deficient anemia from heavy cycles is common and treatable.
• Comprehensive metabolic panel.
• Vitamin D and B12. Both meaningfully affect mood and energy.
• Fasting insulin, HbA1c, and ApoB. Cardiometabolic risk shifts during this transition and is worth knowing about.
• Sometimes a sex-hormone-binding globulin and total testosterone, especially if libido or energy is a major complaint.

We do not lean on a single FSH value to "make the diagnosis." Perimenopause is a clinical diagnosis built on symptoms plus pattern.

What the evidence actually says about hormone therapy

The Women's Health Initiative (WHI) study in 2002 created two decades of fear around hormone therapy. The reanalysis since then has been substantial and important. The summary, as best we currently understand it:

• For healthy women under 60 (or within 10 years of menopause) starting hormone therapy, the risk-benefit profile is favorable. Cardiovascular risk is not increased and may be reduced. Breast cancer risk increases marginally with combined estrogen-plus-progestin therapy over years but the absolute risk remains small for most women. Bone protection is real.
• The form matters. Transdermal estradiol (patch, gel) does not carry the venous thromboembolism risk that oral estrogen does. Micronized progesterone has a better profile than older synthetic progestins.
• For women with a uterus, progesterone is needed to protect the endometrium when estrogen is given.
• For women without a uterus, estrogen alone is the standard.
• Vaginal estrogen for genitourinary symptoms is one of the safest interventions in medicine and is wildly underutilized.
• The "you can only take HRT for 5 years" rule has been retired. Duration is a conversation, not a hard cutoff.

The 2022 NAMS (North American Menopause Society) position statement is the current best summary of the evidence. We use it as our reference point in clinic.

How perimenopause care works at Fishtown Medicine

The first visit is 90 minutes. We build the history, decide on labs, talk about whether the symptoms suggest a trial of hormone therapy or whether we want to optimize sleep, nutrition, and lifestyle first. Most patients leave the first visit with a plan that addresses the top one or two symptoms most disruptive to their life, plus a labs order. We follow up at four to six weeks to talk through results and adjust. If we start hormone therapy, we follow up at three months and then every six months unless something changes. Beyond hormones, we address what tends to get neglected at the standard visit: sleep architecture, resistance training (the single most important intervention for bone and metabolic health in this decade), protein intake, alcohol, and a real conversation about cardiovascular risk because the trajectory shifts in this window.

What it costs

Membership at Fishtown Medicine is $250 per month, $685 per quarter, or $2,500 per year if paid annually. All visits are covered. Hormone therapy prescriptions, labs, and follow-up are inside the relationship; medications are billed through pharmacy (cash or insurance). Transdermal estradiol and micronized progesterone are typically inexpensive at most Philadelphia pharmacies with cash pricing.

Key Takeaways

• Perimenopause is the 4-to-10 year hormonal transition that precedes menopause, usually starting in the late 30s or 40s.
• The driver is hormonal variability, not steady decline.
• The diagnosis is clinical; labs are confirmatory rather than screening.
• The 2002 WHI scare has been substantially revised; for most women under 60, modern hormone therapy is safe and effective.
• Fishtown Medicine treats perimenopause as a real condition with real time, real options, and real follow-up.

Related Services and Reading

• Menopause Care in Philadelphia - what happens after the transition.
• Hormone Optimization in Philadelphia - the broader hormones framing.
• Perimenopause Pillar - the deeper clinical guide.
• Menopause 3.0 - long-form modern menopause.
• Women's Hormone Health Pillar - the umbrella framing.
• Postpartum Care in Philadelphia - the earlier hormonal transition many of the same patients went through.
• Direct Primary Care in Philadelphia - how membership covers this kind of care.

---